ClinicalTrials.Veeva

Menu

Quantitative Assessment of Orofacial Muscle Function in FSHD

U

University of Mons

Status

Completed

Conditions

Facioscapulohumeral Muscular Dystrophy

Treatments

Procedure: Measurement of maximal expiratory pressures during forced static expiratory maneuvers sustained over 5 seconds

Study type

Interventional

Funder types

Other

Identifiers

NCT06425445
P2024/031

Details and patient eligibility

About

The goal of this study is to validate a new method for the assessment of orofacial muscles in FSHD affected individuals, using maximal expiratory pressures (MEPs).

Our hypothesis is the following:

  • The pressure drop observed when using circular mouthpieces (versus ovoid mouthpieces) is a reflection of orofacial dysfunction in FSHD affected individuals

Enrollment

22 patients

Sex

All

Ages

15 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Genetic diagnosis of FSHD type 1 and/or type 2

Exclusion criteria

  • Pregnant women
  • Presence of other associated neuromuscular conditions
  • Any unstable interfering clinical situation

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

22 participants in 2 patient groups

Affected participants
Experimental group
Treatment:
Procedure: Measurement of maximal expiratory pressures during forced static expiratory maneuvers sustained over 5 seconds
Healthy participants
Experimental group
Treatment:
Procedure: Measurement of maximal expiratory pressures during forced static expiratory maneuvers sustained over 5 seconds

Trial contacts and locations

1

Loading...

Central trial contact

Alexandre Legrand (PhD, MD, principal investigator); Eliot Rudy Mbolo Ebubu (PhD candidate, MD, study investigator)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems